CRISPR technologies in chinese hamster ovary cell line engineering

K Glinšek, K Bozovičar, T Bratkovič - International journal of molecular …, 2023 - mdpi.com
The Chinese hamster ovary (CHO) cell line is a well-established platform for the production
of biopharmaceuticals due to its ability to express complex therapeutic proteins with human …

Expanding the CRISPR Toolbox for Engineering Lycopene Biosynthesis in Corynebacterium glutamicum

Z Zhan, X Chen, Z Ye, M Zhao, C Li, S Gao, AJ Sinskey… - Microorganisms, 2024 - mdpi.com
Lycopene represents one of the central compounds in the carotenoid pathway and it exhibits
a potent antioxidant ability with wide potential applications in medicine, food, and cosmetics …

Cas12a and MAD7, genome editing tools for breeding

S Hozumi, YC Chen, T Takemoto… - Breeding …, 2024 - jstage.jst.go.jp
Food shortages due to population growth and climate change are expected to occur in the
near future as a problem that urgently requires solutions. Conventional breeding techniques …

[HTML][HTML] CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells

A Vlassis, TL Jensen, M Mohr, DJ Jedrzejczyk, X Meng… - Iscience, 2023 - cell.com
Discovery of genomic safe harbor sites (SHSs) is fundamental for multiple transgene
integrations, such as reporter genes, chimeric antigen receptors (CARs), and safety …

Application of CRISPR/Cas9 Genome Editing to Improve

JS Lee, HF Kildegaard - … Production in CHO Cells: Methods and …, 2025 - books.google.com
Genome editing has become an important aspect of Chinese hamster ovary (CHO) cell line
engineering for improving the production of recombinant protein therapeutics. Currently, the …

The CRISPR Cas patent files, part 2: Is Cpf1/Cas12a a less conflict-prone alternative to Cas9?

U Storz - Journal of Biotechnology, 2024 - Elsevier
CRISPR Cpf1/Cas12a has been discussed as a less conflict prone alternative, patent-wise,
to Cas9. This article investigates whether or not this assumption is correct, and comes to the …

Mixing four Cell lines to produce an Antibody cocktail as a Next-generation antivenom-a Case study with a “mixed” Outcome

AC Adams - 2023 - orbit.dtu.dk
Snakebite envenoming is a neglected tropical disease that is treated with antivenom based
on polyclonal antibodies derived from the plasma of hyperimmunized animals, such as …

Navigating biomanufacturing challenges in the use of CHO cells for recombinant adeno-associated virus production

DC Tatjer - 2024 - orbit.dtu.dk
The initial goal of this project was to investigate different production methods for
recombinant adeno-associated virus (rAAV), with a special emphasisonChinese hamster …

Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells

LM Grav, JB Rojek, KJ la Cour Karottki, JS Lee… - … Protein Production in …, 2024 - Springer
Genome editing has become an important aspect of Chinese hamster ovary (CHO) cell line
engineering for improving the production of recombinant protein therapeutics. Currently, the …